東華大學圖書館 |

語系: 繁體中文

說明(常見問題)

回圖書館首頁

手機版館藏查詢

登入

回首頁

切換: 標籤 | MARC模式 | ISBD

Identification of Host-Targeting Ant...

Gupta, Amita.

FindBook

Google Book

Amazon

博客來

Identification of Host-Targeting Antiviral Drug Combinations and Targets.

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	Identification of Host-Targeting Antiviral Drug Combinations and Targets./
作者:	Gupta, Amita.
出版者:	Ann Arbor : ProQuest Dissertations & Theses, : 2020,
面頁冊數:	127 p.
附註:	Source: Dissertations Abstracts International, Volume: 82-01, Section: B.
Contained By:	Dissertations Abstracts International82-01B.
標題:	Infections. -
電子資源:	https://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=28103838
ISBN:	9798662478503

Identification of Host-Targeting Antiviral Drug Combinations and Targets.
Gupta, Amita.

Identification of Host-Targeting Antiviral Drug Combinations and Targets. - Ann Arbor : ProQuest Dissertations & Theses, 2020 - 127 p.

Source: Dissertations Abstracts International, Volume: 82-01, Section: B.

Thesis (Ph.D.)--Stanford University, 2020.

This item must not be sold to any third party vendors.

Despite remarkable progress in the last fifty years in the fight against infectious disease, diverse viruses continue to pose major global health challenges. There is a critical need for rapidly deployable, broad-spectrum antiviral therapies. Generally, antiviral therapies are either direct-acting antivirals (DAAs) or host-targeted therapies. This thesis focuses on exploring the potential of and mechanisms underlying two distinct host-targeting antiviral strategies. Firstly, we explore combination therapies comprising inhibitors of de novo pyrimidine biosynthesis-a host-targeting antiviral strategy that has been shown to be effective in vitro against > 30 diverse DNA and RNA viruses. To improve their efficacy under physiologically relevant conditions, we combine inhibitors of the de novo pyrimidine biosynthesis with inhibitors of nucleoside salvage and transport. Using the salvage inhibitor cyclopentenyl uracil (CPU), we successfully demonstrate antiviral activity of this combination in the context of dengue infection. Furthermore, we demonstrate that the efficacy of direct-acting antivirals such as RNA-dependent RNA-polymerase (RdRp) inhibitors can be enhanced via modulation of pyrimidine biosynthesis. This proof-of-concept paves the way for dual virus and host-targeting strategies. Additionally, we perform a genome-wide analysis of human targets of the macrolide antibiotic josamycin. Macrolide antibiotics are commonly prescribed for their ability to inhibit bacterial protein synthesis. However, it is increasingly recognized that they also possess non-canonical anti-viral and other therapeutic activities in mammalian cells. To better understand their modes of action in mammalian cells, we performed a genome-wide shRNA screen in K562 cancer cells to identify genes that modulate sensitivity to josamycin. We report diverse mammalian targets including mitochondrial translation, glycolysis and the mitogen activated protein kinase (MAPK) cascade. This work demonstrates the utility of genome-wide approaches for drug target identification and uncovers human targets of this antibiotic class in an unbiased fashion.

ISBN: 9798662478503Subjects--Topical Terms:

1621997
Infections.
Subjects--Index Terms:

Pyrimidine

Identification of Host-Targeting Antiviral Drug Combinations and Targets.
LDR:03385nmm a2200385 4500 001 2279615
005 20210823080258.5
008 220723s2020 ||||||||||||||||| ||eng d
020 $a 9798662478503
035 $a (MiAaPQ)AAI28103838
035 $a (MiAaPQ)STANFORDfz131jn1975
035 $a AAI28103838
040 $a MiAaPQ $c MiAaPQ
100 1 $a Gupta, Amita. $3 3558075
245 1 0 $a Identification of Host-Targeting Antiviral Drug Combinations and Targets.
260 1 $a Ann Arbor : $b ProQuest Dissertations & Theses, $c 2020
300 $a 127 p.
500 $a Source: Dissertations Abstracts International, Volume: 82-01, Section: B.
500 $a Includes supplementary digital materials.
500 $a Advisor: Bassik, Michael;Khosla, Chaitan;Sattely, Elizabeth.
502 $a Thesis (Ph.D.)--Stanford University, 2020.
506 $a This item must not be sold to any third party vendors.
520 $a Despite remarkable progress in the last fifty years in the fight against infectious disease, diverse viruses continue to pose major global health challenges. There is a critical need for rapidly deployable, broad-spectrum antiviral therapies. Generally, antiviral therapies are either direct-acting antivirals (DAAs) or host-targeted therapies. This thesis focuses on exploring the potential of and mechanisms underlying two distinct host-targeting antiviral strategies. Firstly, we explore combination therapies comprising inhibitors of de novo pyrimidine biosynthesis-a host-targeting antiviral strategy that has been shown to be effective in vitro against > 30 diverse DNA and RNA viruses. To improve their efficacy under physiologically relevant conditions, we combine inhibitors of the de novo pyrimidine biosynthesis with inhibitors of nucleoside salvage and transport. Using the salvage inhibitor cyclopentenyl uracil (CPU), we successfully demonstrate antiviral activity of this combination in the context of dengue infection. Furthermore, we demonstrate that the efficacy of direct-acting antivirals such as RNA-dependent RNA-polymerase (RdRp) inhibitors can be enhanced via modulation of pyrimidine biosynthesis. This proof-of-concept paves the way for dual virus and host-targeting strategies. Additionally, we perform a genome-wide analysis of human targets of the macrolide antibiotic josamycin. Macrolide antibiotics are commonly prescribed for their ability to inhibit bacterial protein synthesis. However, it is increasingly recognized that they also possess non-canonical anti-viral and other therapeutic activities in mammalian cells. To better understand their modes of action in mammalian cells, we performed a genome-wide shRNA screen in K562 cancer cells to identify genes that modulate sensitivity to josamycin. We report diverse mammalian targets including mitochondrial translation, glycolysis and the mitogen activated protein kinase (MAPK) cascade. This work demonstrates the utility of genome-wide approaches for drug target identification and uncovers human targets of this antibiotic class in an unbiased fashion.
590 $a School code: 0212.
650 4 $a Infections. $3 1621997
650 4 $a Gene expression. $3 643979
650 4 $a Zika virus. $3 3319806
650 4 $a Neutrophils. $3 878084
650 4 $a Biosynthesis. $3 516407
650 4 $a Antibiotics. $3 670318
650 4 $a Influenza. $3 924085
650 4 $a Deoxyribonucleic acid--DNA. $3 3546879
650 4 $a Respiratory syncytial virus. $3 3558076
650 4 $a Genomes. $3 592593
650 4 $a Stem cells. $3 767761
650 4 $a Kinases. $3 3558077
650 4 $a Chronic obstructive pulmonary disease. $3 3558078
650 4 $a Cell cycle. $3 766119
650 4 $a Proteins. $3 558769
650 4 $a Bioinformatics. $3 553671
650 4 $a Bioengineering. $3 657580
650 4 $a Pharmacology. $3 634543
650 4 $a Chemical engineering. $3 560457
653 $a Pyrimidine
653 $a Macrolide antibiotics
653 $a Josamycin
690 $a 0202
690 $a 0542
690 $a 0419
690 $a 0715
710 2 $a Stanford University. $3 754827
773 0 $t Dissertations Abstracts International $g 82-01B.
790 $a 0212
791 $a Ph.D.
792 $a 2020
793 $a English
856 4 0 $u https://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=28103838